Aldagen
Latest round
- Series D
Last raised
- Apr 2008
Total raised
- $55M
Investors
- 10
About Aldagen
Aldagen specializes in developing cell-based therapies aimed at treating various diseases. Founded by professionals with extensive backgrounds in biotechnology, the company is headquartered in Durham, US.10 mn.com specializes in the buying and leasing of domain names, offering a streamlined platform for individuals and businesses looking to establish or enhance their online presence.com priced at USD 4,888. Customers can also opt for a lease-to-own arrangement at USD 172 per month, making it accessible for various budgets. The platform is designed to facilitate safe and secure transactions, ensuring users can confidently make purchases or engage in leasing agreements.com caters to a broad range of clients, including small businesses, startups, and individual entrepreneurs across various geographical markets, including North America, Europe, and parts of Asia.com generates revenue primarily through the sale and leasing of domain names. The business model involves direct transactions with customers, where clients can choose to either buy a domain outright or enter a lease-to-own agreement.com would have the option to pay a one-time fee of USD 4,888 or opt for a monthly payment plan of USD 172, facilitating easier access to premium domain names. The company’s revenue structure emphasizes direct-to-consumer sales, with each transaction designed to be simple and secure, reflecting the company's commitment to providing hassle-free payment solutions.Aldagen is focusing on expanding its product offerings, particularly in the realm of innovative cell-based therapies.59 mn in VENTURE DEBT, will be utilized to support research and development of new therapeutic solutions. Additionally, the company plans to expand its market reach into new geographic regions, aiming for an entry into Europe and Asia by the end of 2024.
Who invested in Aldagen
10 investors across 5 rounds
See all investors in Aldagen
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Aldagen
Who invested in Aldagen?
Aldagen has 10 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Aldagen raised?
Aldagen has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Aldagen last raise money?
Aldagen's most recent round on record is a Series D, in Apr 2008.
What does Aldagen do?
Aldagen specializes in developing cell-based therapies aimed at treating various diseases.
Where is Aldagen headquartered?
Aldagen is headquartered in Durham, US.
Which VCs invest in companies like Aldagen?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Aldagen's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Aldagen? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.